1.Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR, Flotte T, Gregory K, Puliafito CA, Fujimoto JG: Optical Coherence Tomography. Science. 1991; 254:1178-1181.

2.Brezinski ME: Optical Coherence Tomography: Principle and Practice. Burlington: Academic Press; 2006.

3.Brezinski ME, Tearney GJ, Bouma BE, Izatt JA, Hee MR, Swanson EA, Southern JF, Fujimoto JG: Optical coherence tomography for optical biopsy - Properties and demonstration of vascular pathology. Circulation. 1996; 93:1206-1213.

4.Brezinski ME, Tearney GJ, Bouma BE, Boppart SA, Hee MR, Swanson EA, Southern JF, Fujimoto JG: Imaging of coronary artery microstructure (in vitro) with optical coherence tomography. American Journal Of Cardiology. 1996; 77:92-93.

5.Swanson EA, Huang D, Hee MR, Fujimoto JG, Lin CP, Puliafito CA: High-Speed Optical Coherence Domain Reflectometry. Optics Letters. 1992; 17:151-153.

6.Eickhoff W, Ulrich R: Optical Frequency-Domain Reflectometry In Single-Mode Fiber. Applied Physics Letters. 1981; 39:693-695.

7.Brezinski ME, Tearney GJ, Weissman NJ, Boppart SA, Bouma BE, Hee MR, Weyman AE, Swanson EA, Southern JF, Fujimoto JG: Assessing atherosclerotic plaque morphology: Comparison of optical coherence tomography and high frequency intravascular ultrasound. Heart. 1997; 77:397-403.

8.Patwari P, Weissman NJ, Boppart SA, Jesser C, Stamper D, Fujimoto JG, Brezinski ME: Assessment of coronary plaque with optical coherence tomography and high-frequency ultrasound. American Journal Of Cardiology. 2000; 85:641-644.

9.Fujimoto JG, Boppart SA, Tearney GJ, Bouma BE, Pitris C, Brezinski ME: High resolution in vivo intra-arterial imaging with optical coherence tomography. Heart. 1999; 82:128-133.

10.Drexler W, Stamper D, Jesser C, Li XD, Pitris C, Saunders K, Martin S, Lodge MB, Fujimoto JG, Brezinski ME: Correlation of collagen organization with polarization sensitive imaging of in vitro cartilage: Implications for osteoarthritis. Journal Of Rheumatology. 2001; 28:1311-1318.

11.Rogowska J, Brezinski ME: Evaluation of the adaptive speckle suppression filter for coronary optical coherence tomography imaging. IEEE Transactions On Medical Imaging. 2000; 19:1261-1266.

12.Schmitt JM: OCT elastography: imaging microscopic deformation and strain of tissue. Optics Express. 1998; 3:199-211.

13.Boppart SA, Brezinski ME, Bouma BE, Tearney GJ, Fujimoto JG: Investigation of developing embryonic morphology using optical coherence tomography. Developmental Biology. 1996; 177:54-63.

14.Tearney GJ, Brezinski ME, Bouma BE, Boppart SA, Pitris C, Southern JF, Fujimoto JG: In vivo endoscopic optical biopsy with optical coherence tomography. Science. 1997; 276:2037-2039.

15.Chinn SR, Swanson EA, Fujimoto JG: Optical coherence tomography using a frequency-tunable optical source. Optics Letters. 1997; 22:340-342.

17.Giattina SD, Courtney BK, Herz PR, Harman M, Shortkroff S, Stamper DL, Liu B, Fujimoto JG, Brezinski ME: Assessment of coronary plaque collagen with polarization sensitive optical coherence tomography (PS-OCT). Int J Cardiol. 2006; 107:400-409.

18.Boppart SA, Brezinski ME, Fujimoto JG: Optical coherence tomography imaging in developmental biology. Methods Mol Biol. 2000; 135:217-233.

19.Dave DP, Akkin T, Milner TE, Rylander HG: Phase-sensitive frequency-multiplexed optical low-coherence reflectometery. Optics Communications. 2001; 193:39-43.

20.Schmitt JM, Xiang SH, Yung KM: Differential absorption imaging with optical coherence tomography. Journal Of The Optical Society Of America A-Optics Image Science And Vision. 1998; 15:2288-2296.

21.Liu B, MacDonald EA, Stamper DL, Brezinski ME: Group velocity dispersion effects with water and lipid in 1.3 mu m optical coherence tomography system. Physics In Medicine And Biology. 2004; 49:923-930.

22.Brezinski ME: Optical coherence tomography for identifying unstable coronary plaque. International Journal Of Cardiology. 2006; 107:154-165.

23.Farooq MU, Khasnis A, Majid A, Kassab MY: The role of optical coherence tomography in vascular medicine. Vascular Medicine. 2009; 14:63-71.

24.Parsa P, Jacques SL, Nishioka NS: Optical-Properties Of Rat-Liver Between 350 And 2200 Nm. Applied Optics. 1989; 28:2325-2330.

25.Li XD, Gold H, Weissman NJ, Ghanta R, Pitris C, Guerrera JL, Jesser C, Fujimoto JG, Brezinski ME: High-resolution imaging of stents andplaques with optical coherence tomography. In The 72nd Scientific Sessions, American Heart Association; Nov. 7-10; Atlanta, GA. 1999.

26.Tearney GJ, Jang IK, Kang DH, Aretz HT, Houser SL, Brady TJ, Schlendorf K, Shishkov M, Bouma BE: Porcine coronary imaging in vivo by optical coherence tomography. Acta Cardiologica. 2000; 55:233-237.

27.Jang IK, Bouma BE, Kang DH, Park SJ, Park SW, Seung KB, Choi KB, Shishkov M, Schlendorf K, Pomerantsev E, et al: Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: Comparison with intravascular ultrasound. Journal Of The American College Of Cardiology. 2002; 39:604-609.

28.Liu B, Brezinski ME: Theoretical and practical considerations on detection performance of time domain, Fourier domain, and swept source optical coherence tomography. Journal Of Biomedical Optics. 2007; 12.

29.Zheng K, Liu B, Huang CY, Brezinski ME: Experimental confirmation of potential swept source optical coherence tomography performance limitations. Applied Optics. 2008; 47:6151-6158.

30.Barlis P, Schmitt J: Current and future developments in intracoronary optical coherence tomography imaging. EuroIntervention. 2009; 4:529.

31.Prati F, Cera M, Ramazzotti V, Imola F, Giudice R, Giudice M, De Propris S, Albertucci M: From bench to bedside - A novel technique of acquiring OCT images. Circulation Journal. 2008; 72:839-843.

32.Brezinski M, Saunders K, Jesser C, Li XD, Fujimoto J: Index matching to improve optical coherence tomography imaging through blood. Circulation. 2001; 103:1999-2003.

33.Tearney GJ, Yabushita H, Houser SL, Aretz HT, Jang IK, Schlendorf KH, Kauffman CR, Shishkov M, Halpern EF, Bouma BE: Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation. 2003; 107:113-119.

34.MacNeill BD, Jang IK, Bouma BE, Iftimia N, Takano M, Yabushita H, Shishkov M, Kaufman CR, Houser SL, Aretz HT, et al: Focal and multi-focal plaque distributions in patients with macrophage acute and stable presentations of coronary artery disease. Journal Of The American College Of Cardiology. 2004; 44:972-979.

35.Raffel OC, Tearney GJ, Gauthier DD, Halpern EF, Bouma BE, Jang IK: Relationship between a systemic inflammatory marker, plaque inflammation, and plaque characteristics determined by intravascular optical coherence tomography. Arteriosclerosis Thrombosis And Vascular Biology. 2007; 27:1820-1827.

36.Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, et al: Optimal medical therapy with or without PCI for stable coronary disease. New England Journal Of Medicine. 2007; 356:1503-1516.

37.Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Sophia V, Morger C, Kukreja N, Juni P, Sianos G, Hellige G, et al: Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007; 369:667-678.

38.Dawkins KD, Grube E, Guagliumi G, Banning AP, Zmudka K, Colombo A, Thuesen L, Hauptman K, Marco J, Wijns W, et al: Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial - Support for the use of drug-eluting Stents in contemporary clinical practice. Circulation. 2005; 112:3306-3313.

39.Urban P, Gershlick AH, Guagliumi G, Guyon P, Lotan C, Schofer J, Seth A, Sousa JE, Wijns W, Berge C, et al: Safety of coronary Sirolimus-Eluting Stents in daily clinical practice - One-year follow-up of the e-cypher registry. Circulation. 2006; 113:1434-1441.

40.Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, et al: Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. Jama-Journal Of The American Medical Association. 2005; 293:2126-2130.

41.Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC, Kim SW, Bui A, Gevorkian N, Xue ZY, et al: Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 2006; 113:1108-1113.

42.Grines CL, Bonow RO, Casey DE, Gardner TJ, Lockhart PB, Moliterno DJ, O'Gara P, Whitlow P: Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents - A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation. 2007; 115:813-818.

43.Suzuki Y, Ikeno F, Koizumi T, Tio F, Yeung A, Yock PG, J. FP, F. FW: In vivo comparison between optical coherence tomography and intravascular ultrasound for detecting small degrees of in-stent neointima after stent implantation. JACC Cardiovasc Intervent. 2008; 1:168-173.

44.Di Mario C, Barlis P: Optical coherence tomography. Anew tool to detect tissue coverage in drug-eluting stents. JACC Cardiovasc Intervent. 2008; 1:174-175.

45.Kume T, Akaska T, Kawamoto T, Watanabe N, Toyota E, Sukmawan R, Sudahira Y, Yoshida K: Visualization of neointima formation by optical coherence tomography. Int Heart J. 2005; 46:1133-1136.

46.Matsumoto D, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D, Sawada T, Paredes OL, Hirata KI, Yokoyama M: Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. European Heart Journal. 2007; 28:961-967.

47.Diaz-Sandoval LJ, Bouma BE, Tearney GJ, Jang IK: Optical coherence tomography as a tool for percutaneous coronary interventions. Catheter Cardiovasc Interv. 2005; 65:492-496.

48.Regar E, Schaar J, Serruys PW: Acute recoil in sirolimus eluting stent: real time, in vivo assessment with optical coherence tomography. Heart. 2006; 92:123-123.

49.Suzuki Y, Ikeno F, Yeung AC: Drug-eluting stent strut distribution: a comparison between Cypher and Taxus by optical coherence tomography. J Invasive Cardiol. 2006; 18:111-114.

50.Yao ZH, Matsubara T, Inada T, Suzuki Y, Suzuki T: Neointimal coverage of sirolimus-eluting stents 6 months and 12 months after implantation: evaluation by optical coherence tomography. Chinese Medical Journal. 2008; 121:503-507.

51.Tanigawa J, Barlis P, Dimopoulos K, Dalby M, Moore P, Di Mario C: The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography. International Journal Of Cardiology. 2009; 134:180-188.

52.Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, Vogel R, Hess O, Meier B, Windecker S: Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation. 2007; 115:2426-2434.

53.Hassan A, Bergheanu S, van der Hoeven BL, Snoep JD, Plevier JW, Schalij MJ, Jukema JW: Late stent malappoistion risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. Eur Heart J. 2009: Electronic publication ahead of print.

54.Hong MK, Mintz GS, Lee CW, Park DW, Park KM, Lee BK, Kim YH, Song JM, Han KH, Kang DH, et al: Late stent malapposition after drug-eluting stent implantation - An intravascular ultrasound analysis with long-term follow-up. Circulation. 2006; 113:414-419.

55.Tian F, Chen YD, Sun ZJ, Chen L, Yuan F, Song XT, Lu SZ: Evaluation of neointimal coverage of overlapping sirolimus-eluting stents by optical coherence tomography. Chinese Medical Journal. 2009; 122:670-674.

56.Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, Gold HK, Virmani R: Pathological correlates of late drug-eluting stent thrombosis - Strut coverage as a marker of endothelialization. Circulation. 2007; 115:2435-2441.

57.Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, Kramer JM, Harrington RA, Matchar DB, Kandzari DE, et al: Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. Jama-Journal Of The American Medical Association. 2007; 297:159-168.

58.Falk E: Plaque Rupture With Severe Pre-Existing Stenosis Precipitating Coronary-Thrombosis - Characteristics Of Coronary Atherosclerotic Plaques Underlying Fatal Occlusive Thrombi. British Heart Journal. 1983; 50:127-134.

59.Davies MJ: Stability and instability: Two faces of coronary atherosclerosis - The Paul Dudley White Lecture 1995. Circulation. 1996; 94:2013-2020.

60.Farb A, Burke AP, Tang AL, Liang YH, Mannan P, Smialek J, Virmani R: Coronary plaque erosion without rupture into a lipid core - A frequent cause of coronary thrombosis in sudden coronary death. Circulation. 1996; 93:1354-1363.

61.Falk E, Shah PK, Fuster V: Coronary Plaque Disruption. Circulation. 1995; 92:657-671.

62.Rioufol G, Finet G, Ginon I, Andre-Fouet X, Rossi R, Vialle E, Desjoyaux E, Convert G, Huret JF, Tabib A: Multiple atherosclerotic plaque rupture in acute coronary syndrome - A three-vessel intravascular ultrasound study. Circulation. 2002; 106:804-808.

63.Okura H, Kobayashi Y, Sumitsuji S, Terashima M, Shimada K, Masutani M, Ohyanagi M, Kataoka T, Taguchi H, Yasuga Y, et al: Baseline and follow-up three-vessel intravascular ultrasound evaluation of plaque rupture in acute coronary syndrome. Circulation. 2005; 112:3579.

64.Burke AP, Kolodgie FD, Farb A, Weber D, Virmani R: Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation. 2002; 105:297-303.

65.Mann J, Davies MJ: Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart. 1999. 82:265-268.

66.Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O'Neill WW: Multiple complex coronary plaques in patients with acute myocardial infarction. New England Journal Of Medicine. 2000; 343:915-922.

67.Maehara A, Mintz GS, Bui AB, Walter OR, Castagna MT, Canos D, Pichard AD, Satler LF, Waksman R, Suddath WO, et al: Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound. Journal Of The American College Of Cardiology. 2002; 40:904-910.

68.Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM: Lessons from sudden coronary death - A comprehensive morphological classification scheme for atherosclerotic lesions. Arteriosclerosis Thrombosis And Vascular Biology. 2000; 20:1262-1275.

69.Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R: Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. New England Journal Of Medicine. 1997; 336:1276-1282.

70.Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T, Tanimoto T, Matsuo Y, Masho T, Kitabata H, et al: Assessment of culprit lesion morphology in acute myocardial infarction - Ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. Journal Of The American College Of Cardiology. 2007; 50:933-939.

71.Mehta SK, McCrary JR, Frutkin AD, Dolla WJS, Marso SP: Intravascular ultrasound radiofrequency analysis of coronary atherosclerosis: an emerging technology for the assessment of vulnerable plaque. European Heart Journal. 2007; 28:1283-1288.

72.Kume T, Akasaka T, Kawamoto T, Okura H, Watanabe N, Toyota E, Neishi Y, Sukmawan R, Sadahira Y, Yoshida K: Measurement of the thickness of the fibrous cap by optical coherence tomography. American Heart Journal. 2006; 152.

73.Yabushita H, Bourna BE, Houser SL, Aretz T, Jang IK, Schlendorf KH, Kauffman CR, Shishkov M, Kang DH, Halpern EF, Tearney GJ: Characterization of human atherosclerosis by optical coherence tomography. Circulation. 2002; 106:1640-1645.

74.Rieber J, Meissner O, Babaryka G, Reim S, Oswald M, Koenig A, Schiele TM, Shapiro M, Theisen K, Reiser MF, et al: Diagnostic accuracy of optical coherence tomography and intravascular ultrasound for the detection and characterization of atherosclerotic plaque composition in ex-vivo coronary specimens: a comparison with histology. Coronary Artery Disease. 2006; 17:425-430.

75.Shah PK, Falk E, Badimon JJ, Fernandezortiz A, Mailhac A, Villareallevy G, Fallon JT, Regnstrom J, Fuster V: Human Monocyte-Derived Macrophages Induce Collagen Breakdown In Fibrous Caps Of Atherosclerotic Plaques - Potential Role Of Matrix-Degrading Metalloproteinases And Implications For Plaque Rupture. Circulation. 1995; 92:1565-1569.

76.Libby P: Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001; 104:365-372.

77.Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, Maseri A: Widespread coronary inflammation in unstable angina. New England Journal Of Medicine. 2002; 347:5-12.

78.Tofler GH, Stone PH, Maclure M, Edelman E, Davis VG, Robertson T, Antman EM, Muller JE: Analysis Of Possible Triggers Of Acute Myocardial-Infarction (The Milis Study). American Journal Of Cardiology. 1990; 66:22-27.

79.Rogowska J, Patel NA, Fujimoto JG, Brezinski ME: Optical coherence tomographic elastography technique for measuring deformation and strain of atherosclerotic tissues. Heart. 2004; 90:556-562.

80.Nadkarni SK, Pierce MC, Park BH, de Boer JF, Whittaker P, Bouma BE, Bressner JE, Halpern E, Houser SL, Tearney GJ: Measurement of collagen and smooth muscle cell content in atherosclerotic plaques using polarization-sensitive optical coherence tomography. Journal Of The American College Of Cardiology. 2007; 49:1474-1481.

81.Rogowska J, Patel N, Plummer S, Brezinski ME: Quantitative optical coherence tomographic elastography: method for assessing arterial mechanical properties. British Journal Of Radiology. 2006; 79:707-711.

82.Oldenburg AL, Gunther JR, Boppart SA: Imaging magnetically labeled cells with magnetomotive optical coherence tomography. Optics Letters. 2005; 30:747-749.

83.Rao KD, Choma MA, Yazdanfar S, Rollins AM, Izatt JA: Molecular contrast in optical coherence tomography by use of a pump-probe technique. Optics Letters. 2003; 28:340-342.

84.Yang CH, Choma MA, Lamb LE, Simon JD, Izatt JA: Protein-based molecular contrast optical coherence tomography with phytochrome as the contrast agent. Optics Letters. 2004; 29:1396-1398.

85.Zheng K, Rashidifard C, Liu B, Brezinski ME: Comparison of artifact generation with catheter bending using different PS-OCT approaches. Reports in Medical Imaging. 2009; 2:1-6.

86.Li XD, Martin S, Pitris C, Ghanta R, Stamper DL, Harman M, Fujimoto JG, Brezinski ME: High-resolution optical coherence tomographic imaging of osteoarthritic cartilage during open knee surgery. Arthritis Research & Therapy. 2005; 7:R318-R323.

87.Zheng K, Martin S, Rashidifard C, Liu B, Brezinski ME: In Vivo Micron Scale Arthroscopic Imaging of Human Knee Osteoarthritis with OCT: Comparison with MRI and Arthroscopy. The American Journal Of Orthopedics :In Press.

88.Rollins AM, Yazdanfar S, Barton JK, Izatt JA: Real-time in vivo colors Doppler optical coherence tomography. Journal Of Biomedical Optics. 2002; 7:123-129.

89.Brezinski ME, Liu B: Nonlocal quantum macroscopic superposition in a high-thermal low-purity state. Physical Review A 2008, 78.

90.Kume T, Akasaka T, Kawamoto T, Ogasawara Y, Watanabe N, Toyota E, Neishi Y, Sukmawan R, Sadahira Y, Yoshida K: Assessment of coronary arterial plaques by optical coherence tomography. American Journal Of Cardiology. 2006; 97:1172-1175.

91.Manfrini O, Mont E, Leone O, Arbustini E, Eusebi V, Virmani R, Bugiardini R: Sources of error and interpretation of plaque morphology by optical coherence tomography. American Journal Of Cardiology. 2006; 98:156-159.

92.Raffel OC, Akasaka T, Jang IK: Cardiac optical coherence tomography. Heart. 2008; 94:1200-1210.

93.Park BH, Saxer C, Srinivas SM, Nelson JS, de Boer JF: In vivo burn depth determination by high-speed fiber-based polarization sensitive optical coherence tomography. Journal Of Biomedical Optics. 2001; 6:474-479.

94.Takada K, Yokohama I, Chida K, Noda J: New Measurement System For Fault Location In Optical Wave-Guide Devices Based On An Interferometric-Technique. Applied Optics. 1987; 26:1603-1606.

95.Liu B, Harman M, Brezinski ME: Variables affecting polarization-sensitive optical coherence tomography imaging examined through the modeling of birefringent phantoms. Journal Of The Optical Society Of America A-Optics Image Science And Vision. 2005; 22:262-271.

96.Liu B, Harman M, Giattina S, Stamper DL, Demakis C, Chilek M, Raby S, Brezinski ME: Characterizing of tissue microstructure with single-detector polarization-sensitive optical coherence tomography. Applied Optics. 2006; 45:4464-4479.

98.  Azimi, E., Liu, B., Brezinski, M.E., 2009. Real-time and high performance calibration method for high-speed SS-OCT, J. Biomed. Opt. (In Press);

99.  Liu, B., Azimi, E., Brezinski, M.E., 2009. Improvement in dynamic range limitation of SS-OCT by true logarithmic amplification, J. Opt. Soc. Am. A (in press).

100. Fujii, K., M. Masutani, T. Okumura, D. Kawasak, T. Akagami, A. Ezumi, T. Sakoda, T. Masuyama, and M. Ohyanagi: Frequency and Predictor of Coronary Thin-Cap Fibroatheroma in Patients With Acute Myocardial Infarction Stable Angina Pectoris: A 3-Vessel Optical Coherence Tomography Study. Journal of the American College of Cardiology 52: 787-788

101. Kim K.H., Park B. H., Maguluri G.N., Lee T.W., Rogomentich F.J., Bancu M.G., Bouma B.E., de Boer J.F., and Bernstein J.J.  Two-axis magnetically-driven MEMS scanning catheter for endoscopic high-speed optical coherence tomography.  Opt Express. 2007 Dec 24;15(26):18130-40.

102. Ophir J, Cespedes I, et al., Elastography: a Quantitative Method for Imaging the Elasticity of Biological Tissues, Ultrason imaging, 13:111-134, 1991

103. de Korte C.L., Cespedes, I., et al., Intravascular Elasticity Imaging using Ultrasound, Ultrasound Med Biol, 23:725-746, 1997

104. de Korte, C.L. and van der Steen, A.F., Intravascular Ultrasound Elastography: an Overview, Ultrasonics, 40(1-8):859-65, 2002

105. Erkamp, R.Q., Wiggins, P., et al., Measuring the Elastic Modulus of Small Tissue Samples, Ultrason Imaging, 20:17-28,1998

106. Gao, L., Parker, K.J., et al., Imaging of the Elastic Properties of Tissue: a Review,  Ultrasound Med Biol, 22(8):959-977, 1996

107. Greenleaf, J.F., Fatemi, M., et al., Selected Methods for Imaging Elastic Properties of Biological Tissues, Annu Rev of Biomed Eng, 5:57-78, 2003

108. Shapo, B.M., Crowe, J.R., et al., Strain Imaging of Coronary Arteries with Intraluminal Ultrasound: Experiments on an Inhomogeneous Phantom, Ultrason Imaging, 18:173-191, 1996

109. Wilson, L.S., Robinson, D.E., et al., Elastography - the Movement Begins,  Phys Med Biol, 45:1409-1421, 2000

110. van der Steen, A., de Korte, C.L., et al., Intravascular Elastography,  Ultraschall Med, 19:196-201, 1998

111. Feynman, R.P., Leighton, R.B., and Sands, M., The Feyman Lectures on Physics.

112. Rogowska, J., Fujimoto, J.G., and M.E. Brezinski, Optical Coherence Tomographic Elastography Technique for Measuring Deformation and Strain of Atherosclerotic Tissues, Heart, 90:556-562, 2004

113. Rogowska, J., Patel, N., et al., Quantitative Optical Coherence Tomography Elastography: Method for Assessing Arterial Mechanical Properties, The Br. J. Radiol. 79:707-711.

114. Schmitt, J., OCT Elastography: Imaging Microscopic Deformation and Strain of Tissue, Optics Express, 6:199-211,1998

115. deKorte, C.L., van der Steen, A.F., et al., Characterization of Plaque Components and Vulnerability with Intravascular Elastography, Phys. Med. Biol, 45: 1465-1475, 2000.

116. Kallel, F. and Bertrand, M., Tissue Elasticity Reconstruction Using Linear Perturbation Method, IEEE Transsactions on Medical Imaging, Vol 15, 299-313, 1996

117. Konofagou, E., and Ophir, J., A New Elastographic Method for Estimation and Imaging of Lateral Displacements, Lateral Strains, and Poisson’s Ratios in Tissues, Ultrasound in Med. and Biol, 24: 1183-1199, 1998

118. Janssen, C.R., de Korte, C.L., et al., Angle Matching in Intravascular Elastography, Ultrasonics, 38: 417-423, 2000

119. Bhide, A, 1996.  The Questions Every Entrepreneur Must Answer.  Harvard Business Review.  Nov. 120-130.

120. Porter, M.E., 1996. What is Strategy.  Harvard Business Review.  Nov. 61-80.